Europe vs South Africa: Proportion of the target population who received the final dose of
Europe
40.0%
in 2024
South Africa
79.0%
in 2024
Europe rank
21st
South Africa rank
24th
Proportion of the target population who received the final dose of over time
- Europe
- South Africa
How they compare
South Africa currently reports 79.0% against 40.0% in Europe, a difference of 39.0%.
That makes South Africa's figure about 2.0 times Europe's.
The two have swapped places 2 times across 11 shared years of data; in 2014 it was South Africa ahead.
Europe ranks 21st and South Africa ranks 24th of 35 groups.
South Africa has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Europe | South Africa | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 32.5% | 55.0% | 22.5% | South Africa |
| 2020s | 36.8% | 47.0% | 10.2% | South Africa |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received the final dose of, Europe or South Africa?
- South Africa, at 79.0% against 40.0% in Europe as of 2024.
- What is the difference in proportion of the target population who received the final dose of between Europe and South Africa?
- 39.0%, with South Africa ahead.
- How many years of comparable data are there for Europe and South Africa?
- 11 years are reported by both, from 2014 to 2024.
- How do Europe and South Africa rank globally for proportion of the target population who received the final dose of?
- Europe ranks 21st and South Africa ranks 24th of 35 groups.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received the final dose of human papillomavirus (HPV) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.